Navigation Links
Cardinal Health Appoints Bruce Downey to Board of Directors; John McCoy Retires From Board After 22 Years
Date:7/2/2009

DUBLIN, Ohio, July 2 /PRNewswire-FirstCall/ -- Cardinal Health today announced that Bruce L. Downey will join the company's board of directors effective upon the completion of the planned spinoff of CareFusion Corporation, replacing John B. McCoy who has retired from the board for personal reasons after 22 years of service to the company as a director.

Downey is the former chairman and chief executive officer of Barr Pharmaceuticals, Inc. and past chairman of the Generic Pharmaceutical Association.

"John McCoy has been a committed board member for more than two decades, and we extend our sincere appreciation for the invaluable guidance he has provided during a tenure that helped transform Cardinal Health into the industry leader it is today," said R. Kerry Clark, Cardinal Health chairman and chief executive officer. "John has been part of a tremendous growth story since 1987, and we wish him well in the future."

Downey served from 1994 to 2008 as chairman and chief executive officer of Barr, a global specialty pharmaceutical company that operated in more than 30 countries. During Downey's tenure at Barr, the company grew revenue from $60 million to more than $2.5 billion and became the fourth largest global generic drug company prior to its acquisition by Teva. Prior to joining Barr, Downey was a partner at the law firm of Winston and Strawn. He began his career in the Honors Program of the U.S. Department of Justice. He later worked as a special litigation counsel at the U.S. Department of Energy.

Downey currently serves as the chair of the Board of Ambassadors for Johns Hopkins' Project RESTORE, which funds research and clinical trials to support the creation of progressive treatments for transverse myelitis and multiple sclerosis. He also serves on the board of Momenta Pharmaceuticals and is a partner in NewSpring Health II, a venture capital firm.

"We are thrilled that Bruce will be joining the board of the 'new' Cardinal Health," said George Barrett, future chairman and chief executive officer of Cardinal Health. "Bruce is a dynamic and creative leader who will bring unique perspectives to our company. We look forward to welcoming him to our board following completion of the planned spinoff."

About Cardinal Health

Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is a $91 billion, global company serving the health care industry with products and services that help hospitals, physician offices and pharmacies reduce costs, improve safety, productivity and profitability, and deliver better care to patients. With a focus on making supply chains more efficient, reducing hospital-acquired infections and breaking the cycle of harmful medication errors, Cardinal Health develops market-leading technologies, including Alaris(R) IV pumps, Pyxis(R) automated dispensing and patient identification systems, MedMined(TM) electronic infection surveillance service and VIASYS(R) respiratory care products. The company also manufactures medical and surgical products and is one of the largest distributors of pharmaceuticals and medical supplies worldwide. Ranked No. 18 on the Fortune 500, Cardinal Health employs more than 40,000 people on five continents. More information about the company may be found at www.cardinalhealth.com.


'/>"/>
SOURCE Cardinal Health, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Boston Cardinal OMalley Withdraws Caritas Christi From Potential Abortion Scandal
2. Cardinal Health Foundation Awards $1 Million to Fund Patient Safety Initiatives
3. Cardinal Health Investor and Analyst Advisory
4. Cardinal Health Increases Quarterly Dividend By 25 Percent
5. Cardinal George Praises President Obamas Promise to Support Conscience Clauses, Seeks to Work With Administration on Goal
6. Cardinal Health to Offer Allscripts Electronic Health Record to Solo and Small Physician Groups
7. Cardinal Health Board Proposes Employee Stock Option Exchange Program, Declares Regular Quarterly Dividend
8. Cardinal Health Reports Third Quarter Results
9. The Ohio State University, Cardinal Health, State of Ohio to Invest $10 Million to Advance Medical Imaging Industry
10. Cardinal Rigali Praises House Re-Introduction of Pregnant Women Support Act, Urges Co-Sponsorship
11. Cardinal Rigali Criticizes Draft NIH Guidelines for Destructive Stem Cell Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... ... ... Shark Finds and Kevin Harrington, and the Product Managers of AsSeenOnTV.pro are pleased to ... patented product that has solved some of the basic problems golfers have faced since the ... right after a rain shower, might understand the struggle of placing the club down for ...
(Date:2/8/2016)... ... 08, 2016 , ... The Federal Laboratory Consortium for Technology ... site houses a wealth of federal resources that businesses can leverage to further ... transfer (T2). As a network of over 300 federal laboratories, the FLC’s mission ...
(Date:2/8/2016)... ... 2016 , ... Stephanie Hebert Insurance Agency, serving families of ... charity campaign. As part of their ongoing community involvement program, funds are now ... children deserve a voice, and in the spirit of neighbors helping neighbors in ...
(Date:2/8/2016)... Alexandria, Minn. (PRWEB) , ... February 08, 2016 ... ... introduces the BantamPro L top-load case packer for pouches, bags, and flow wrapped ... designed to help co-packers and specialty product manufacturers step up to semi-automatic or ...
(Date:2/8/2016)... Island, SC (PRWEB) , ... February 08, 2016 , ... ... surrounding areas with a vital new community enrichment program, has teamed up with Citizens ... women and children suffering from intimate abuse. To support all those victimized by the ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... ORLANDO, Florida , February 9, 2016 /PRNewswire/ ... QIA) today announced a collaboration with 10x Genomics ... sequencing (NGS), single-cell biology and bioinformatics. --> ... announced a collaboration with 10x Genomics to develop ... single-cell biology and bioinformatics. --> QIAGEN ...
(Date:2/9/2016)... Mast Therapeutics, Inc. (NYSE MKT: MSTX), ... disease and heart failure, today announced that it intends to ... stock in an underwritten public offering.  The offering is subject ... assurance as to whether or when the offering may be ... the offering.   --> --> ...
(Date:2/9/2016)... , February 9, 2016 ... company focused on developing products for Regenerative Medicine, Neurology ... a featured presenting company at Source Capital Group,s 2016 ... February 10-11, 2016 in New York City ... Wednesday, February 10, 2016 at 12:30 pm by ...
Breaking Medicine Technology: